Share This Article:

Metabolic Syndrome and DNA Damage: The Interplay of Environmental and Lifestyle Factors in the Development of Metabolic Dysfunction

Full-Text HTML XML Download Download as PDF (Size:494KB) PP. 65-76
DOI: 10.4236/ojemd.2015.57009    3,617 Downloads   4,560 Views   Citations


The Metabolic Syndrome (MetS) is a complex condition which is characterized by increased risk factor for cardiovascular diseases, such as dyslipidemia, hypertension and central obesity, in addition to increased risk for type 2 diabetes mellitus (T2DM). All of these factors alone have a notable relationship with DNA damage. However, when the risks are combined, the extent for major outcomes being related to DNA damage (cancer), the consequence can be accelerated by the metabolic dysfunction. This article will illustrate the scientific evidence of the role of DNA damage in MetS, as well as discuss the interplay of major risks factors (air pollution, physical inactivity and dietary interventions) in genomic stability.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Stefani, G. , Baldissera, G. , Nunes, R. , Heck, T. and Rhoden, C. (2015) Metabolic Syndrome and DNA Damage: The Interplay of Environmental and Lifestyle Factors in the Development of Metabolic Dysfunction. Open Journal of Endocrine and Metabolic Diseases, 5, 65-76. doi: 10.4236/ojemd.2015.57009.


[1] Cameron, A.J., Shaw, J.E. and Zimmet, P.Z. (2004) The Metabolic Syndrome: Prevalence in Worldwide Populations. Endocrinology and Metabolism Clinics of North America, 33, 351-375.
[2] Cowey, S. and Hardy, R.W. (2006) The Metabolic Syndrome: A High-Risk State for Cancer? The American Journal of Pathology, 169, 1505-1522.
[3] Grundy, S.M. (2008) Metabolic Syndrome Pandemic. Arterioscler Thromb Vasc Biol., 28, 629-636.
[4] Alberti, K.G., Zimmet, P. and Shaw, J. (2005) The Metabolic Syndrome—A New Worldwide Definition. The Lancet, 366, 1059-1062.
[5] Fajersztajn, L., Veras, M., Barrozo, L.V. and Saldiva, P. (2013) Air Pollution: A Potentially Modifiable Risk Factor for Lung Cancer. Nature Reviews Cancer, 13, 674-678.
[6] Lepeule, J., Laden, F., Dockery, D. and Schwartz, J. (2012) Chronic Exposure to Fine Particles and Mortality: An Extended Follow-Up of the Harvard Six Cities Study from 1974 to 2009. Environmental Health Perspectives, 120, 965-970.
[7] Pope 3rd, C.A., et al. (2002) Lung Cancer, Cardiopulmonary Mortality, and Long-Term Exposure to Fine Particulate Air Pollution. JAMA, 287, 1132-1141.
[8] Eze, I.C., et al. (2014) Long-Term Air Pollution Exposure and Diabetes in a Population-Based Swiss Cohort. Environment International, 70, 95-105.
[9] Furukawa, S., et al. (2004) Increased Oxidative Stress in Obesity and Its Impact on Metabolic Syndrome. Journal of Clinical Investigation, 114, 1752-1761.
[10] Roberts, C.K. and Sindhu, K.K. (2009) Oxidative Stress and Metabolic Syndrome. Life Sciences, 84, 705-712.
[11] Schafer, F.Q. and Buettner, G.R. (2001) Redox Environment of the Cell as Viewed through the Redox State of the Glutathione Disulfide/Glutathione Couple. Free Radical Biology and Medicine, 30, 1191-1212.
[12] Pinkhasov, B.B., Selyatitskaya, V.G., Karapetyan, A.R. and Astrakhantseva, E.L. (2012) Metabolic Syndrome in Men and Women with Upper or Lower Types of Body Fat Distribution. Health, 4, 1381-1389.
[13] Nawrocki, A.R. and Scherer, P.E. (2004) The Delicate Balance between Fat and Muscle: Adipokines in Metabolic Disease and Musculoskeletal Inflammation. Current Opinion in Pharmacology, 4, 281-289.
[14] Srinivasan, V., Ohta, Y., Espino, J., Pariente, J.A., Rodriguez, A.B., Mohamed, M., et al. (2013) Metabolic Syndrome, Its Pathophysiology and the Role of Melatonin. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 7, 11-25.
[15] Ren, J. (2004) Leptin and Hyperleptinemia—From Friend to Foe for Cardiovascular Function. Journal of Endocrinology, 181, 1-10.
[16] Sweeney, G. (2010) Cardiovascular Effects of Leptin. Nature Reviews Cardiology, 7, 22-29.
[17] Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K. and Tobe, K. (2006) Adiponectin and Adiponectin Receptors in Insulin Resistance, Diabetes, and the Metabolic Syndrome. Journal of Clinical Investigation, 116, 1784-1792.
[18] Tesauro, M., Canale, M.P., Rodia, G., Di Daniele, N., Lauro, D., Scuteri, A., et al. (2011) Metabolic Syndrome, Chronic Kidney, and Cardiovascular Diseases: Role of Adipokines. Cardiology Research and Practice, 2011, Article ID: 653182.
[19] Heck, T.G., Ludwig, M.S., Montagner, G.F.F.S. and Frizzo, M.N. (2015) Subclinical Processes in the Development of Type Two Diabetes. Journal of Novel Physiotherapies, 5, 246.
[20] Tangvarasittichai, S. (2015) Oxidative Stress, Insulin Resistance, Dyslipidemia and Type 2 Diabetes Mellitus. World Journal of Diabetes, 6, 456-480.
[21] Nowotny, K., Jung, T., Hohn, A., Weber, D. and Grune, T. (2015) Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus. Biomolecules, 5, 194-222.
[22] Venkatasamy, V.V., Pericherla, S., Manthuruthil, S., Mishra, S. and Hanno, R. (2013) Effect of Physical Activity on Insulin Resistance, Inflammation and Oxidative Stress in Diabetes Mellitus. Journal of Clinical and Diagnostic Research: JCDR, 7, 1764-1766.
[23] Erol, A. (2010) Systemic DNA Damage Response and Metabolic Syndrome as a Premalignant State. Current Molecular Medicine, 10, 321-334.
[24] Nystrom, F.H. and Quon, M.J. (1999) Insulin Signalling: Metabolic Pathways and Mechanisms for Specificity. Cellular Signalling, 11, 563-574.
[25] Surova, O. and Zhivotovsky, B. (2013) Various Modes of Cell Death Induced by DNA Damage. Oncogene, 32, 3789-3797.
[26] Harrison, D.G. and Gongora, M.C. (2009) Oxidative Stress and Hypertension. Medical Clinics of North America, 93, 621-635.
[27] Fujita, T. (2007) Insulin Resistance and Salt-Sensitive Hypertension in Metabolic Syndrome. Nephrology Dialysis Transplantation, 22, 3102-3107.
[28] Fujita, T. (2008) Aldosterone in Salt-Sensitive Hypertension and Metabolic Syndrome. Journal of Molecular Medicine, 86, 729-734.
[29] Redon, J., Oliva, M.R., Tormos, C., Giner, V., Chaves, J., Iradi, A., et al. (2003) Antioxidant Activities and Oxidative Stress Byproducts in Human Hypertension. Hypertension, 41, 1096-1101.
[30] Homem de Bittencourt Jr., P.I., Lagranha, D.J., Maslinkiewicz, A., Senna, S.M., Tavares, A.M.V., Baldissera, L.P., et al. (2007) LipoCardium: Endothelium-Directed Cyclopentenone Prostaglandin-Based Liposome Formulation That Completely Reverses Atherosclerotic Lesions. Atherosclerosis, 193, 245-258.
[31] Tornovsky-Babeay, S., Dadon, D., Ziv, O., Tzipilevich, E., Kadosh, T., Haroush, R.S.-B., et al. (2014) Type 2 Diabetes and Congenital Hyperinsulinism Cause DNA Double-Strand Breaks and p53 Activity in Beta Cells. Cell Metabolism, 19, 109-121.
[32] Hutcheson, R. and Rocic, P. (2012) The Metabolic Syndrome, Oxidative Stress, Environment, and Cardiovascular Disease: The Great Exploration. Experimental Diabetes Research, 2012, Article ID: 271028.
[33] Giacco, F. and Brownlee, M. (2010) Oxidative Stress and Diabetic Complications. Circulation Research, 107, 1058-1070.
[34] Robertson, R.P., Harmon, J., Tran, P.O. and Poitout, V. (2004) Beta-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes. Diabetes, 53, S119-S124.
[35] Chung, J., Nguyen, A.-K., Henstridge, D.C., Holmes, A.G., Chan, M.H.S., Mesa, J.L., et al. (2008) HSP72 Protects against Obesity-Induced Insulin Resistance. Proceedings of the National Academy of Sciences of the United States of America, 105, 1739-1744.
[36] Di Naso, F.C., Porto, R.R., Fillmann, H.S., Maggioni, L., Padoin, A.V., Ramos, R.J., et al. (2015) Obesity Depresses the Anti-Inflammatory HSP70 Pathway, Contributing to NAFLD Progression. Obesity, 23, 120-129.
[37] Ludwig, M.S., Minguetti-Camara, V.C., Heck, T.G., Scomazzon, S.P., Nunes, P.R., Bazotte, R.B., et al. (2014) Short-Term but Not Long-Term Hypoglycaemia Enhances Plasma Levels and Hepatic Expression of HSP72 in Insulin-Treated Rats: An Effect Associated with Increased IL-6 Levels but Not with IL-10 or TNF-alpha. Molecular and Cellular Biochemistry, 397, 97-107.
[38] Heck, T.G., Scholer, C.M. and de Bittencourt, P.I. (2011) HSP70 Expression: Does It a Novel Fatigue Signalling Factor from Immune System to the Brain? Cell Biochemistry and Function, 29, 215-226.
[39] Rodrigues-Krause, J., Krause, M., O’Hagan, C., De Vito, G., Boreham, C., Murphy, C., et al. (2012) Divergence of Intracellular and Extracellular HSP72 in Type 2 Diabetes: DOES Fat Matter? Cell Stress and Chaperones, 17, 293-302.
[40] Chouchane, L., Danguir, J., Beji, C., Bouassida, K., Camoin, L., Sfar, H., et al. (2001) Genetic Variation in the Stress Protein hsp70-2 Gene Is Highly Associated with Obesity. International Journal of Obesity, 25, 462-466.
[41] Feng, B., Ruiz, M.A. and Chakrabarti, S. (2013) Oxidative-Stress-Induced Epigenetic Changes in Chronic Diabetic Complications. Canadian Journal of Physiology and Pharmacology, 91, 213-220.
[42] Hazra, T.K., Das, A., Das, S., Choudhury, S., Kow, Y.W. and Roy, R. (2007) Oxidative DNA Damage Repair in Mammalian Cells: A New Perspective. DNA Repair, 6, 470-480.
[43] El-Wassef, M., El-Saeed, G.S.M., El-Tokhy, S.E., Raslan, H.M., Tawfeek, S., Siam, I., et al. (2012) Oxidative DNA Damage in Patients with Type 2 Diabetes Mellitus. Diabetologia Croatica, 41, 121-127.
[44] Boldogh, I., Hajas, G., Aguilera-Aguirre, L., Hegde, M.L., Radak, Z., Bacsi, A., et al. (2012) Activation of Ras Signaling Pathway by 8-Oxoguanine DNA Glycosylase Bound to Its Excision Product, 8-Oxoguanine. The Journal of Biological Chemistry, 287, 20769-20773.
[45] Dianov, G.L. and Hubscher, U. (2013) Mammalian Base Excision Repair: The Forgotten Archangel. Nucleic Acids Research, 41, 3483-3490.
[46] Panier, S. and Boulton, S.J. (2014) Double-Strand Break Repair: 53BP1 Comes into Focus. Nature Reviews Molecular Cell Biology, 15, 7-18.
[47] Srivastava, M. and Raghavan, S.C. (2015) DNA Double-Strand Break Repair Inhibitors as Cancer Therapeutics. Chemistry & Biology, 22, 17-29.
[48] Karaman, A., Aydin, H., Geckinli, B., Cetinkaya, A. and Karaman, S. (2015) DNA Damage Is Increased in Lymphocytes of Patients with Metabolic Syndrome. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 782, 30-35.
[49] Fenech, M. (2007) Cytokinesis-Block Micronucleus Cytome Assay. Nature Protocols, 2, 1084-1104.
[50] Calle, E.E. and Kaaks, R. (2004) Overweight, Obesity and Cancer: Epidemiological Evidence and Proposed Mechanisms. Nature Reviews Cancer, 4, 579-591.
[51] Yuzefovych, L.V., Musiyenko, S.I., Wilson, G.L. and Rachek, L.I. (2013) Mitochondrial DNA Damage and Dysfunction, and Oxidative Stress Are Associated with Endoplasmic Reticulum Stress, Protein Degradation and Apoptosis in High Fat Diet-Induced Insulin Resistance Mice. PLoS ONE, 8, e54059.
[52] Gong, J., Zhu, T., Kipen, H., Wang, G., Hu, M., Guo, Q., et al. (2014) Comparisons of Ultrafine and Fine Particles in Their Associations with Biomarkers Reflecting Physiological Pathways. Environmental Science & Technology, 48, 5264-5273.
[53] Brook, R.D., Rajagopalan, S., Arden Pope III, C., Brook, J.R., Bhatnagar, A., Diez-Roux, A.V., et al. (2010) Particulate Matter Air Pollution and Cardiovascular Disease: An Update to the Scientific Statement from the American Heart Association. Circulation, 121, 2331-2378.
[54] Martinelli, N., Olivieri, O. and Girelli, D. (2013) Air Particulate Matter and Cardiovascular Disease: A Narrative Review. European Journal of Internal Medicine, 24, 295-302.
[55] Sawyer, K., Mundandhara, S., Ghio, A.J. and Madden, M.C. (2010) The Effects of Ambient Particulate Matter on Human Alveolar Macrophage Oxidative and Inflammatory Responses. Journal of Toxicology and Environmental Health, Part A, 73, 41-57.
[56] Kannan, S., Misra, D.P., Dvonch, J.T. and Krishnakumar, A. (2006) Exposures to Airborne Particulate Matter and Adverse Perinatal Outcomes: A Biologically Plausible Mechanistic Framework for Exploring Potential Effect Modification by Nutrition. Environmental Health Perspectives, 114, 1636-1642.
[57] Risom, L., M?ller, P. and Loft, S. (2005) Oxidative Stress-Induced DNA Damage by Particulate Air Pollution. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 592, 119-137.
[58] Apeagyei, E., Bank, M.S. and Spengler, J.D. (2011) Distribution of Heavy Metals in Road Dust Along an Urban-Rural Gradient in Massachusetts. Atmospheric Environment, 45, 2310-2323.
[59] Lawson, S.J., Galbally, I.E., Powell, J.C., Keywood, M.D., Molloy, S.B., Cheng, M., et al. (2011) The Effect of Proximity to Major Roads on Indoor Air Quality in Typical Australian Dwellings. Atmospheric Environment, 45, 2252-2259.
[60] Garte, S., Gaspari, L., Alexandrie, A.K., Ambrosone, C., Autrup, H., Autrup, J.L., et al. (2001) Metabolic Gene Polymorphism Frequencies in Control Populations. Cancer Epidemiology, Biomarkers & Prevention, 10, 1239-1248.
[61] Devlin, R.B., C.B. Smith, M.T. Schmitt, A.G. Rappold, A. Hinderliter, D. Graff, et al. (2014) Controlled Exposure of Humans with Metabolic Syndrome to Concentrated Ultrafine Ambient Particulate Matter Causes Cardiovascular Effects. Toxicological Sciences, 140, 61-72.
[62] Abdilla, N., Tormo, M.C., Fabia, M.J., Chaves, F.J., Saez, G. and Redon, J. (2007) Impact of the Components of Metabolic Syndrome on Oxidative Stress and Enzymatic Antioxidant Activity in Essential Hypertension. Journal of Human Hypertension, 21, 68-75.
[63] WHO (2010) Global Recommendations on Physical Activity for Health. WHO Press, Genebra, 1-60.
[64] (2009) Part A: Executive Summary. Nutrition Reviews, 67, 114-120.
[65] Warburton, D.E., Charlesworth, S., Ivey, A., Nettlefold, L. and Bredin, S.S. (2010) A Systematic Review of the Evidence for Canada’s Physical Activity Guidelines for Adults. International Journal of Behavioral Nutrition and Physical Activity, 7, 39.
[66] Rodgers, A., Ezzati, M., Vander Hoorn, S., Lopez, A.D., Lin, R.-B. and Murray, C.J.L. (2004) Distribution of Major Health Risks: Findings from the Global Burden of Disease Study. PLoS Medicine, 1, e27.
[67] Lee, I.M., Shiroma, E.J., Lobelo, F., Puska, P., Blair, S.N. and Katzmarzyk, P.T. (2012) Effect of Physical Inactivity on Major Non-Communicable Diseases Worldwide: An Analysis of Burden of Disease and Life Expectancy. The Lancet, 380, 219-229.
[68] Yokota, T., Kinugawa, S., Yamato, M., Hirabayashi, K., Suga, T., Takada, S., et al. (2013) Systemic Oxidative Stress Is Associated with Lower Aerobic Capacity and Impaired Skeletal Muscle Energy Metabolism in Patients with Metabolic Syndrome. Diabetes Care, 36, 1341-1346.
[69] Samjoo, I.A., Safdar, A., Hamadeh, M.J., Raha, S. and Tarnopolsky, M.A. (2013) The Effect of Endurance Exercise on Both Skeletal Muscle and Systemic Oxidative Stress in Previously Sedentary Obese Men. Nutrition & Diabetes, 3, e88.
[70] Strasser, B., Arvandi, M. and Siebert, U. (2012) Resistance Training, Visceral Obesity and Inflammatory Response: A Review of the Evidence. Obesity Reviews, 13, 578-591.
[71] Giles, L.V. and Koehle, M.S. (2014) The Health Effects of Exercising in Air Pollution. Sports Medicine, 44, 223-249.
[72] Heck, T.G., Petry, M.R., Maslinkiewicz, A., Goettems-Fiorin, P.B., Ludwig, M.S., Saldiva, P.H.N., et al. (2014) Residual Oil Fly Ash (ROFA) Inhalation Promotes Lung and Heart Oxidative Stress without Hemodynamic Effects in Exercising Rats. Journal of Exercise Physiology online, 17, 78-89.
[73] Heck, T.G., Petry, M.R., Maslinkiewicz, A., Goettems-Fiorin, P.B., Ludwig, M.S., Saldiva, P.H.N., et al. (2014) Effects of Ambient Particles Inhalation on Lung Oxidative Stress Parameters in Exercising Rats. Journal of Exercise Physiology online, 17, 58-69.
[74] Radak, Z., Atalay, M., Jakus, J., Boldogh, I., Davies, K., Goto, S., et al. (2009) Exercise Improves Import of 8-Oxoguanine DNA Glycosylase into the Mitochondrial Matrix of Skeletal Muscle and Enhances the Relative Activity. Free Radical Biology and Medicine, 46, 238-243.
[75] Lopez-Uriarte, P., Nogués, R., Saez, G., Bulló, M., Romeu, M., Masana, L., et al. (2010) Effect of Nut Consumption on Oxidative Stress and the Endothelial Function in Metabolic Syndrome. Clinical Nutrition, 29, 373-380.
[76] Sabate, J., Oda, K. and Ros, E. (2010) Nut Consumption and Blood Lipid Levels: A Pooled Analysis of 25 Intervention Trials. Archives of Internal Medicine, 170, 821-827.
[77] Bao, Y., Han, J., Hu, F.B., Giovannucci, E.L., Stampfer, M.J., Willett, W.C., et al. (2013) Association of Nut Consumption with Total and Cause-Specific Mortality. New England Journal of Medicine, 369, 2001-2011.
[78] Sedaghat, A., Shahbazian, H., Haidari, F., Payami, S.P., Jahanshahi, A. and Latifi, S.M. (2015) The Effect of Soy Nuts on Glycemic Control, Lipid Profile and Insulin-Resistance in Type 2 Diabetic Patients. Open Journal of Endocrine and Metabolic Diseases, 5, 1-7.
[79] Reis, V.V.C., Coelho, G.M.O., Soares, E.A. and Pereira, A.F. (2014) Effect of Dietetic Intervention in Brazilian Postmenopausal Women with Metabolic Syndrome. Endocrinology & Metabolic Syndrome, 3, 8.
[80] van Dijk, S.J., Feskens, E.J., Bos, M.B., Hoelen, D.W., Heijligenberg, R., Bromhaar, M.G., et al. (2009) A Saturated Fatty Acid-Rich Diet Induces an Obesity-Linked Proinflammatory Gene Expression Profile in Adipose Tissue of Subjects at Risk of Metabolic Syndrome. American Journal of Clinical Nutrition, 90, 1656-1664.
[81] Venturini, D., Simao, A.N., Urbano, M.R. and Dichi, I. (2015) Effects of Extra Virgin Olive Oil and Fish Oil on Lipid Profile and Oxidative Stress in Patients with Metabolic Syndrome. Nutrition, 31, 834-840.
[82] Volek, J.S. and Feinman, R.D. (2005) Carbohydrate Restriction Improves the Features of Metabolic Syndrome. Metabolic Syndrome May Be Defined by the Response to Carbohydrate Restriction. Nutrition & Metabolism, 2, 31.
[83] Esmaillzadeh, A., Kimiagar, M., Mehrabi, Y., Azadbakht, L., Hu, F.B. and Willett, W.C. (2007) Dietary Patterns, Insulin Resistance, and Prevalence of the Metabolic Syndrome in Women. The American Journal of Clinical Nutrition, 85, 910-918.
[84] Mitjavila, M.T., Fandos, M., Salas-Salvadó, J., Covas, M.-I., Borrego, S., Estruch, R., et al. (2013) The Mediterranean Diet Improves the Systemic Lipid and DNA Oxidative Damage in Metabolic Syndrome Individuals. A Randomized, Controlled, Trial. Clinical Nutrition, 32, 172-178.
[85] Schroder, H., Fito, M., Estruch, R., Martinez-Gonzalez, M.A., Corella, D., Salas-Salvado, J., et al. (2011) A Short Screener Is Valid for Assessing Mediterranean Diet Adherence among Older Spanish Men and Women. Journal of Nutrition, 141, 1140-1145.
[86] Kumar, S.A., Magnusson, M., Ward, L.C., Paul, N.A. and Brown, L. (2015) A Green Algae Mixture of Scenedesmus and Schroederiella Attenuates Obesity-Linked Metabolic Syndrome in Rats. Nutrients, 7, 2771-2787.
[87] Poppitt, S.D., Keogh, G.F., Prentice, A.M., Williams, D.E., Sonnemans, H.M., Valk, E.E., et al. (2002) Long-Term Effects of Ad Libitum Low-Fat, High-Carbohydrate Diets on Body Weight and Serum Lipids in Overweight Subjects with Metabolic Syndrome. The American Journal of Clinical Nutrition, 75, 11-20.

comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.